Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
STAAR Surgical Co (STAA)  
$41.02 5.63 (12.07%) as of 4:30 Wed 5/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 51,268,000
Market Cap: 2.10(B)
Last Volume: 1,397,232 Avg Vol: 593,465
52 Week Range: $27.67 - $67.63
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 6.2
Insider 6 Months    : 27.4
Insider 3/6 Months : 34
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. Co.'s products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of Co.'s ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions such as myopia, hyperopia, astigmatism, and presbyopia. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts, and include Co.'s lines of silicone IOLs and the Preloaded Injector.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,750 982,422 1,992,448 2,183,523
Total Buy Value $66,693 $30,859,566 $69,506,378 $78,567,953
Total People Bought 1 4 5 5
Total Buy Transactions 1 24 52 58
Total Shares Sold 0 0 0 157,830
Total Sell Value $0 $0 $0 $10,505,424
Total People Sold 0 0 0 3
Total Sell Transactions 0 0 0 6
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 554
  Page 9 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China   •       –      –    2021-05-24 4 S $130.42 $12,370,989 D/D (94,855) 108,381 4%     
   Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China   •       –      –    2021-05-24 4 OE $7.35 $805,552 D/D 94,855 203,236     -
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2021-05-21 4 S $126.83 $1,935,553 D/D (15,261) 52,630 -1%     
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2021-05-21 4 OE $9.30 $141,927 D/D 15,261 67,891     -
   Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China   •       –      –    2021-05-21 4 S $128.00 $658,560 D/D (5,145) 108,381 -1%     
   Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China   •       –      –    2021-05-21 4 OE $7.35 $45,547 D/D 5,145 113,526     -
   Barnes Scott D Chief Medical Officer   •       –      –    2021-05-21 4 D $126.05 $1,549,785 D/D (12,295) 23,326     -
   Barnes Scott D Chief Medical Officer   •       –      –    2021-05-21 4 OE $16.15 $328,866 D/D 12,295 35,621     -
   Farrell Stephen C Director   –       •      –    2021-05-19 4 D $120.00 $600,000 D/D (5,000) 5,808     -
   Farrell Stephen C Director   –       •      –    2021-05-19 4 OE $5.54 $27,700 D/D 5,000 10,808     -
   Farrell Stephen C Director   –       •      –    2021-05-17 4 D $113.87 $606,699 D/D (5,328) 5,808     -
   Farrell Stephen C Director   –       •      –    2021-05-17 4 OE $7.14 $38,042 D/D 5,328 11,136     -
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2021-05-12 4 OE $16.15 $25,107 D/D 954 9,801     -
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2021-05-12 4 S $110.74 $612,503 D/D (5,531) 8,847 -27%     
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2021-05-11 4 S $111.61 $1,236,081 D/D (11,075) 14,378 -24%     
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2021-05-11 4 OE $27.53 $313,767 D/D 11,075 25,453     -
   Mason Caren L President & CEO   •       •      –    2021-05-11 4 S $110.70 $5,922,450 D/D (53,500) 63,376 -24%     
   Mason Caren L President & CEO   •       •      –    2021-05-11 4 OE $7.76 $415,160 D/D 53,500 116,876     -
   Mason Caren L President & CEO   •       •      –    2021-05-10 4 S $119.88 $6,413,580 D/D (53,500) 63,376 -29%     
   Mason Caren L President & CEO   •       •      –    2021-05-10 4 OE $7.76 $415,160 D/D 53,500 116,876     -
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2021-05-10 4 S $125.72 $1,456,215 D/D (11,583) 52,630 -29%     
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2021-05-10 4 OE $7.35 $86,737 D/D 11,583 64,213     -
   Hayashida Jon K. VP, Global Clinical, Medical   •       –      –    2021-05-10 4 S $124.13 $1,504,561 D/D (12,109) 16,301 -29%     
   Hayashida Jon K. VP, Global Clinical, Medical   •       –      –    2021-05-10 4 OE $16.15 $468,404 D/D 18,719 27,061     -
   Holliday Keith Chief Technology Officer   •       –      –    2021-05-10 4 S $125.83 $1,116,615 D/D (8,874) 22,721 -29%     
  554 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us